Medicare Enrolled
Dr. George Atallah, D.O.
Anesthesiology · Houston, TX
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Atallah from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Atallah?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Atallah
Dr. George Atallah is an anesthesiology specialist in Houston, TX, with 16 years of NPI registration. Based on federal Medicare data, Dr. Atallah performed 4,680 Medicare services across 842 unique beneficiaries.
Between the years covered by Open Payments, Dr. Atallah received a total of $61,728 from 71 pharmaceutical and/or device companies across 1060 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in anesthesiology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Atallah is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 16 years in practice
▲ Top 2% volume in TX
$61,728 industry payments
Medicare Practice Summary
Medicare Utilization ↗4,680
Medicare services
Top 2% in TX for anesthesiology
842
Unique beneficiaries
$53
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~292 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
1,517 | $1 | $5 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,361 | $98 | $405 |
| Drug test with direct observation A drug screening test performed under direct observation to ensure the sample is provided correctly. This method is used to verify the integrity of the specimen collection process. |
321 | $12 | $40 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
230 | $0 | $1 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
186 | $55 | $200 |
| Compounded drug, not otherwise classified A medication prepared specifically for an individual patient by a pharmacist or physician, tailored to meet unique needs that cannot be fulfilled by commercially available products. |
179 | $157 | $525 |
| Spinal drug pump reprogramming and refill A physician electronically adjusts the settings of a spinal drug infusion pump and refills its medication reservoir. |
161 | $74 | $380 |
| Limited abdominal ultrasound A focused ultrasound examination of the abdomen to evaluate specific organs or areas. This procedure uses sound waves to create images of internal structures. |
159 | $69 | $285 |
| Ketorolac injection, per 15 mg An injection of ketorolac tromethamine, a nonsteroidal anti-inflammatory drug, administered in doses measured per 15 mg. |
156 | $0 | $1 |
| Orthovisc intra-articular injection An injection of hyaluronan or its derivative into a joint space to provide lubrication and cushioning. |
81 | $100 | $650 |
| Trigger point injection, 3 or more muscles Injection of medication into three or more specific muscle trigger points to relieve pain. |
70 | $46 | $195 |
| Sacral spine nerve root injection with imaging guidance An injection of anesthetic and/or steroid medication into a sacral spine nerve root. The procedure uses imaging guidance to ensure accurate placement. |
55 | $234 | $790 |
| Injection into lower spine canal with imaging guidance A procedure where a substance is injected into the lower part of the spinal canal. The injection is performed using imaging guidance to ensure accurate placement. |
39 | $205 | $845 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
39 | $123 | $520 |
| Suprascapular nerve injection An injection of anesthetic and/or steroid medication into the suprascapular nerve in the shoulder area. |
34 | $70 | $280 |
| Additional sacral spine nerve root injection with imaging An injection of anesthetic and/or steroid medication into an additional sacral spine nerve root level, guided by imaging. |
31 | $94 | $355 |
| Electronic analysis and reprogramming of spinal drug pump This procedure involves electronically analyzing and reprogramming a spinal canal drug infusion pump. It does not include the surgical insertion or removal of the device. |
28 | $34 | $140 |
| Spine facet joint injection with imaging guidance, single level An injection is administered into a single facet joint of the lower or sacral spine while using imaging guidance to ensure accurate placement. |
17 | $183 | $565 |
| Facet joint injection, second level, with imaging guidance An injection into a lower or sacral spine facet joint using imaging guidance for the second level treated. |
16 | $99 | $290 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$61,728
Total received (2018-2024)
Avg $8,818/year across 7 years
Top 1% in TX for anesthesiology
71
Companies
1,060
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$44,179 (71.6%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$17,549 (28.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$5,497
2023
$6,252
2022
$4,642
2021
$2,546
2020
$5,317
2019
$21,264
2018
$16,212
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Medtronic USA, Inc.
$32,784
Medtronic, Inc.
$8,683
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$4,381
Nevro Corp.
$3,583
Abbott Laboratories
$1,022
Collegium Pharmaceutical, Inc.
$1,015
PFIZER INC.
$846
Boston Scientific Corporation
$737
ABBVIE INC.
$654
Flexion Therapeutics, Inc.
$594
AbbVie Inc.
$537
Allergan, Inc.
$405
Biohaven Pharmaceutical Holding Company Ltd.
$378
PAINTEQ LLC
$371
Scilex Pharmaceuticals Inc.
$352
Lilly USA, LLC
$317
Horizon Therapeutics plc
$282
TerSera Therapeutics LLC
$257
Almatica Pharma LLC
$253
IMPEL PHARMACEUTICALS INC.
$253
Allergan Inc.
$245
BioDelivery Sciences International, Inc.
$240
ARBOR PHARMACEUTICALS, INC.
$237
Eisai Inc.
$234
SCILEX PHARMACEUTICALS INC.
$230
Pacira Therapeutics, Inc.
$229
BOSTON SCIENTIFIC CORPORATION
$180
Azurity Pharmaceuticals, Inc.
$171
Supernus Pharmaceuticals, Inc.
$163
Saluda Medical Americas, Inc.
$142
GRT US Holding, Inc.
$139
Amgen Inc.
$119
RedHill Biopharma Inc.
$117
Vertos Medical, Inc.
$99
Relievant Medsystems, Inc.
$98
Novartis Pharmaceuticals Corporation
$98
Arbor Pharmaceuticals, Inc.
$81
Averitas Pharma Inc.
$79
IDORSIA PHARMACEUTICALS US INC
$79
Zyla Life Sciences
$77
Assertio Therapeutics, Inc.
$72
Teva Pharmaceuticals USA, Inc.
$62
ASSERTIO THERAPEUTICS, Inc.
$61
Daiichi Sankyo Inc.
$50
Nuvectra Corporation
$48
SI-BONE, Inc.
$43
Horizon Pharma plc
$43
Pacira Pharmaceuticals Incorporated
$43
AstraZeneca Pharmaceuticals LP
$41
BIODELIVERY SCIENCES INTERNATIONAL, INC.
$39
Fidia Pharma USA Inc.
$37
Bioventus LLC
$36
Biohaven Pharmaceuticals, Inc.
$34
Pernix Therapeutics Holdings, Inc.
$31
Egalet US Inc
$30
US WorldMeds, LLC
$24
Vertical Pharmaceuticals, LLC
$23
Innovation Technologies Inc
$22
Nalu Medical, Inc.
$22
Spinal Simplicity, LLC
$21
Bausch Health US, LLC
$20
Curonix LLC
$20
Shionogi Inc
$20
Vertiflex, Inc.
$19
Takeda Pharmaceuticals U.S.A., Inc.
$18
Upsher-Smith Laboratories LLC
$17
DePuy Synthes Sales Inc.
$15
Currax Pharmaceuticals LLC
$15
Zyla Life Sciences, Inc.
$15
Medtronic Vascular, Inc.
$14
Stimwave Technologies Incorporated
$14
Top 3 companies account for 74.3% of total payments
Associated products mentioned in payments ›
ACCURIAN · ADAPTIVESTIM · AIMOVIG · AJOVY · ASCENDA · AUTOFILL · Accurian · Aemcolo · Aimovig · Algovita · Amitiza · Axium Sheath Braided DRG · BELBUCA · BOTOX · BOTOX THERAPEUTIC · BUNAVAIL · BUNAVAIL 2.1 mg 30-count box · Belbuca · COMIRNATY · CONTRAVE · Cambia · ClosureFast · DUEXIS · Dayvigo · Durolane · EMGALITY · ETERNA · Evoke · Evoke SCS · Exparel · GENERAL PAIN MANAGEMENT · GENERAL THERAPIES · GRALISE · Gralise · HA MINUTEMAN G3-R · HORIZANT · HYMOVIS · Horizant · INFINION · INTELLIS · INTELLIS ADAPTIVESTIM · IRRISEPT · Intracept · LORZONE · LUCEMYRA · LYRICA · Lucemyra/Lofexidine · MIGRANAL · MOVANTIK · MYSTIM · Morphabond ER · Movantik · NAPRELAN · NURTEC ODT · Nalu Neurostimulation System · Nucynta · ORTHOVISC · Omnia · PAINTEQ · PENNSAID · PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A · PRIALT · PROCLAIM · PlasmaBlade · Prialt · Proclaim Family of SCS IPGs · Proclaim IPG · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · QUTENZA · QUVIVIQ · Qutenza · RAYOS · RELISTOR · RELISTOR ORAL · RESTORE · REYVOW · SPECTRA WAVEWRITER · SPRIX · SUPERION · SYNCHROMED · SYNCHROMEDII · Senza · Senza Spinal Cord Stimulation System · Superion ISS · Superion Indirect Decompression System · Symproic · TROKENDI XR · Talicia · Trudhesa · UBRELVY · V-LOC 180 · VANTA ADAPTIVESTIM · VECTRIS · VIMOVO · WaveWriter Alpha Prime 16 · XTAMPZA · XTAMPZAER · ZOHYDRO ER · ZTLido · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH · Zilretta · Zipsor · iFuse Implant · mild Device Kit
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (72%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in anesthesiology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 1% for anesthesiology in TX.
Equivalent to $1,319 per 100 Medicare services performed
Geographic Context
Anesthesiologists within 10 mi
1,093
Per 100K population
23.0
County median income
$73,104
Nearest hospital
MEMORIAL HERMANN MEMORIAL CITY HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Atallah is a clinical cardiology specialist, with above-average Medicare volume (top 2% in TX), with speaking/promotional industry engagement in the top 1% of TX peers, with 16 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Atallah experienced with steroid injection (triamcinolone)?
Based on Medicare claims data, Dr. Atallah performed 1,517 steroid injection (triamcinolone) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Atallah receive payments from pharmaceutical companies?
Yes. Dr. Atallah received a total of $61,728 from 71 companies across 1,060 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Atallah's costs compare to other anesthesiologists in Houston?
Dr. Atallah's average Medicare payment per service is $53. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Atallah) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Anesthesiologists in Houston
Browse anesthesiologists in Houston ranked by procedure volume and transparency data.
Highest volume
Top Anesthesiologists in TX
Anesthesiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Anesthesiologists in TX
Which TX anesthesiologists receive the most from drug and device companies.
By company
Medtronic USA, Inc. Payments to Doctors
See all physicians who received payments from Medtronic USA, Inc.
By company
Medtronic, Inc. Payments to Doctors
See all physicians who received payments from Medtronic, Inc.
By company
Salix Pharmaceuticals, a division of Bausch Health US, LLC Payments to Doctors
See all physicians who received payments from Salix Pharmaceuticals, a division of Bausch Health US, LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology